TY - JOUR
T1 - Coronary artery anomalies and variants
T2 - Technical feasibility of assessment with coronary MR angiography at 3 T
AU - Gharib, Ahmed M.
AU - Ho, Vincent B.
AU - Rosing, Douglas R.
AU - Herzka, Daniel A.
AU - Stuber, Matthias
AU - Arai, Andrew E.
AU - Pettigrew, Roderic I.
N1 - Copyright:
Copyright 2009 Elsevier B.V., All rights reserved.
PY - 2008/4
Y1 - 2008/4
N2 - The purpose of this study was to prospectively use a whole-heart three-dimensional (3D) coronary magnetic resonance (MR) angiography technique specifically adapted for use at 3 T and a parallel imaging technique (sensitivity encoding) to evaluate coronary arterial anomalies and variants (CAAV). This HIPAA-compliant study was approved by the local institutional review board, and informed consent was obtained from all participants. Twenty-two participants (11 men, 11 women; age range, 18-62 years) were included. Ten participants were healthy volunteers, whereas 12 participants were patients suspected of having CAAV. Coronary MR angiography was performed with a 3-T MR imager. A 3D free-breathing navigator-gated and vector electrocardiographically-gated segmented k-space gradient-echo sequence with adiabatic T2 preparation pulse and parallel imaging (sensitivity encoding) was used. Whole-heart acquisitions (repetition time msec/echo time msec, 4/1.35; 20° flip angle; 1 x 1 x 2-mm acquired voxel size) lasted 10-12 minutes. Mean examination time was 41 minutes ± 14 (standard deviation). Findings included aneurysms, ectasia, arteriovenous fistulas, and anomalous origins. The 3D whole-heart acquisitions developed for use with 3 T are feasible for use in the assessment of CAAV.
AB - The purpose of this study was to prospectively use a whole-heart three-dimensional (3D) coronary magnetic resonance (MR) angiography technique specifically adapted for use at 3 T and a parallel imaging technique (sensitivity encoding) to evaluate coronary arterial anomalies and variants (CAAV). This HIPAA-compliant study was approved by the local institutional review board, and informed consent was obtained from all participants. Twenty-two participants (11 men, 11 women; age range, 18-62 years) were included. Ten participants were healthy volunteers, whereas 12 participants were patients suspected of having CAAV. Coronary MR angiography was performed with a 3-T MR imager. A 3D free-breathing navigator-gated and vector electrocardiographically-gated segmented k-space gradient-echo sequence with adiabatic T2 preparation pulse and parallel imaging (sensitivity encoding) was used. Whole-heart acquisitions (repetition time msec/echo time msec, 4/1.35; 20° flip angle; 1 x 1 x 2-mm acquired voxel size) lasted 10-12 minutes. Mean examination time was 41 minutes ± 14 (standard deviation). Findings included aneurysms, ectasia, arteriovenous fistulas, and anomalous origins. The 3D whole-heart acquisitions developed for use with 3 T are feasible for use in the assessment of CAAV.
UR - http://www.scopus.com/inward/record.url?scp=42449128755&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=42449128755&partnerID=8YFLogxK
U2 - 10.1148/radiol.2471070274
DO - 10.1148/radiol.2471070274
M3 - Article
C2 - 18372470
AN - SCOPUS:42449128755
SN - 0033-8419
VL - 247
SP - 220
EP - 227
JO - Radiology
JF - Radiology
IS - 1
ER -